Diffuse large B-cell lymphoma (DLBCL) and follicular lymphoma (FL) both depend on
immune-mediated survival and proliferation signals from the tumor microenvironment …

B-cell lymphomas can be classified as Hodgkin and non-Hodgkin lymphomas. Diffuse large
B-cell lymphoma (DLBCL) is the most common non-Hodgkin Lymphoma (NHL). The …

A number of studies have investigated the associations between IL-10 polymorphisms and
non-Hodgkin lymphoma (NHL) susceptibility; however, the conclusions were still …

Background Though immunological abnormalities have been proven involved in the
pathogenesis of lymphoma, the underlying mechanism remains unclear. Methods We …

Cancer cell resistance to chemotherapy is a major concern in clinical oncology, resulting in
increased tumor growth and decreased patient survival. Manipulation of apoptosis has …

Introduction: Lymphoma is a common hematopoietic cancer. Immunosuppression is one of
the main risk factors for the development of lymphoma. The interleukin (IL)-1 receptor …

We undertook a hospital-based case-control study to examine the associations between
single nucleotide polymorphisms (SNPs) in selected immunoregulatory genes and non …

Large consortia efforts and genome-wide association studies (GWASs) have linked a
number of genetic variants within the 6p21 chromosomal region to non-Hodgkin lymphoma …

Numerous studies have investigated the association of IL10-819C> T and-592C> A
polymorphisms with non-Hodgkin lymphoma (NHL) susceptibility, and yet reported …

Summary Non-Hodgkin's lymphomas (NHLs) are a diverse group of mature lymphoid
neoplasms with a wide range of cellular, immunological, histological, and molecular …